Quality Resource Guide l Contemporary Approaches to Antibiotic Prophylaxis 3rd Edition 7 www.metdental.com 1. www.census.gov accessed Aug 12, 2019. 2. Miller CS, Epstein JB, Hall EH, Sirois D. Changing oral care needs in the United States: The continuing need for oral medicine Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:34-44. 3. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA 2015 Nov 3; 314(17): 1818-31. 4. Lockhart PB, Loven B, Brennan MT, Baddour LM, Levinson M. The evidence base for the efficiency of antibiotic prophylaxis in dental practice. J Am Dent Assoc 2007; 138(4): 458-74. 5. Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, Strausbaugh LJ. Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin Infect Dis. 2002; 34(12): 1621-1626. 6. Parahitiyawa NB, Jin LJ, Leung WK, Yam WC, Samaranayake LP. Microbiology of odontogenic bacteremia: Beyond endocarditis. Clinical Microbiology Reviews. 2009; 22(1): 46-64. 7. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008; 117(24): 3118-3125. 8. Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK, Sasser H. Poor oral hygiene as a risk factor for infective endocarditis- related bacteremia. J Am Dent Assoc. 2009 Oct; 140(10): 1238-44. 9. Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart 2017;103:937–44. 10. Gary CJ, Glick M. Medical clearance: An issue of professional autonomy, not a crutch. J Am Dent Assoc. 2012;143(11):1180–1181. 11. Infective Endocarditis Brusch JL, Bronze MS, Ed. http://emedicine.medscape.com/ Updated Jan 21, 2021, Accessed Dec 27, 2021. 12. Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One. 2013. 8(3):e60033. 13. Prevention of infective endocarditis: Guidelines from the American Heart Association. Wilson, et al. Jan 2008. J Am Dent Assoc., Volume 139, S3 - S24 14. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017; 135:e1159-e1195. 15. Wilson WR, Gewitz M, Lockhart PB, Bolger AF, DeSimone DC, Kazi DS, Couper DJ, Beaton A, Kilmartin C, Miro JM, Sable C, Jackson MA, Baddour LM; on behalf of the American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021;143:e963–e978. doi: 10.1161/CIR.0000000000000969. 16. Etkin CD, Springer BD. The American Joint Replacement Registry-the first 5 years. Arthroplast Today. 2017;3(2):67-69. Published 2017 Mar 14. doi:10.1016/j.artd.2017.02.002. 17. Sloan M, Premkumar A, Sheth NP. Projected Volume of Primary Total Joint Arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018;100(17):1455- 1460. doi:10.2106/JBJS.17.01617 18. American Dental Association–Appointed Members of the Expert Writing and Voting Panels Contributing to the Development of American Academy of Orthopedic Surgeons Appropriate Use Criteria. J Am Dent Assoc. 2017 Feb;148 (2):57-59. 19. Tande AJ, Patela R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302-345. 20. Lamagni T. Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother. 2014;69(suppl 1):i5-i10. 21. L. Legout, E. Beltrand, H. Migaud, E. Senneville. Antibiotic prophylaxis to reduce the risk of joint implant contamination during dental surgery seems unnecessary. Orthopaedics & Traumatology: Surgery & Research. 2012;98(8):910-914. 22. Témoin S, Chakaki A, Askari A, et al. Identification of oral bacterial DNA in synovial fluid of arthritis patients with native and failed prosthetic joints. Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases. 2012;18(3):117-121. 23. American Dental Association and American Academy of Orthopedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacements 2003. J Am Dent Assoc;134(7):895 – 898. 24. American Academy of Orthopedic Surgery. Information Statement 1033: Antibiotic Prophylaxis for Bacteremia in Patients with Joint Replacements. February 2009. American Academy of Orthopedic Surgeons. 25. Watters W, Rethman MP, Hanson NB, Abt E, Anderson PA, et al. Prevention of orthopedic implant infection in patients undergoing dental procedures. J Am Acad Orthop Surg. 2013;21(3):180-189. 26. Sollecito TP, Abt E, Lockhart PB, Truelove E, Paumier TM, et al. The use of prophylactic antibiotics prior to dental procedures in patients with prosthetic joints: evidence-based clinical practice guideline for dental practitioners—a report of the American Dental Association Council on Scientific Affairs. JADA. 2015;146(1):11-16. 27. Guh AY, Mu Y, Winston LG, et al. Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. N Engl J Med. 2020;382(14):1320- 1330. doi:10.1056/NEJMoa1910215. 28. Centers for Disease Control: Nearly half a million Americans suffered from Clostridium difficile infections in a single year: Accessed July 31st,2017 http://www.cdc.gov/media/releases/2015/p0225- clostridium-difficile.html. 29. CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. 30. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145(10):758-764. 31. Lockhart PB, Blizzard J, Maslow AL, Brennan MT, Sasser H, Carew J. Drug cost implications for antibiotic prophylaxis for dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(3):345-353. 32. Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case control study (published correction appears in Clin Infect Dis. 2010;50(6):944). Clin Infect Dis. 2010;50(1):8-16. 33. American Academy of Orthopaedic Surgeons (AAOS). Appropriate use criteria for the management of patients with orthopaedic implants undergoing dental procedures. Rosemont, IL: AAOS; 2016. Available at: www.orthoguidelines. org/go/auc. 34. Kao FC, Hsu YC, Chen WH, Lin JN, Lo YY, Tu YK. Prosthetic Joint Infection Following Invasive Dental Procedures and Antibiotic Prophylaxis in Patients With Hip or Knee Arthroplasty. Infect Control Hosp Epidemiol. 2017;38(2):154-161. doi:10.1017/ ice.2016.248. References